The M 1/M 4 preferring agonist xanomeline reverses amphetamine-, MK801-and scopolamine-induced abnormalities of latent inhibition: Putative efficacy against positive, negative and cognitive symptoms in schizophrenia

Segev Barak*, Ina Weiner

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'The M 1/M 4 preferring agonist xanomeline reverses amphetamine-, MK801-and scopolamine-induced abnormalities of latent inhibition: Putative efficacy against positive, negative and cognitive symptoms in schizophrenia'. Together they form a unique fingerprint.

Medicine & Life Sciences